News

Arcus Biosciences Welcomes Richard Markus as New CMO

Arcus Biosciences Welcomes Richard Markus as New CMO

Arcus Biosciences Welcomes Richard Markus as Chief Medical Officer

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage biopharmaceutical company known for developing innovative therapies for cancer treatment, is pleased to announce the appointment of Richard Markus, M.D., Ph.D., as its new Chief Medical Officer. This pivotal leadership change is set to enhance the company’s ability to advance its clinical development strategies and deliver groundbreaking treatments to patients in need.

Background on Richard Markus’s Expertise

Dr. Markus brings extensive experience to Arcus, having spent 13 years at Amgen, where he ascended through various roles including Vice President of Global Development. During his tenure, he played a critical role in overseeing the development and approval of multiple products in oncology and other therapeutic areas. Dr. Markus is recognized for spearheading Amgen’s biosimilars division, managing a comprehensive pipeline that promises to change cancer treatment protocols.

Industry Milestones and Innovative Approaches

As the incoming CMO, Dr. Markus will oversee Arcus’s clinical development organization and its late-stage portfolio, which is currently working on four ongoing registrational Phase 3 studies. Among these studies, STAR-221 aims to tackle upper gastrointestinal cancers, and its results are eagerly anticipated. Furthermore, the company plans to initiate a fifth registrational Phase 3 study, PEAK-1, focusing on the treatment of clear-cell renal cell carcinoma (ccRCC).

Comments from Leadership

Terry Rosen, Ph.D., the CEO of Arcus, expressed enthusiasm about Dr. Markus stepping into the CMO role. He believes that Dr. Markus’s vast experience in late-stage development will be crucial in harnessing Arcus's unique portfolio of investigational molecules to address the urgent needs in oncology.

Vision for the Future

Reflecting on the opportunities ahead, Dr. Markus stated, "Joining Arcus is an exciting prospect, particularly given the company’s robust portfolio of innovative cancer assets. I am keen to collaborate with our clinical and business partners to potentially revolutionize standard cancer care through our advanced therapies."

Arcus Biosciences' Clinical Studies Overview

Arcus is making notable strides with its lineup of ongoing and announced clinical studies. Some of the key trials include:

  • Upper Gastrointestinal Cancers: STAR-221 focusing on a combination regimen versus standard options.
  • Lung Cancer Research: The STAR-121 study is currently under a registrational Phase 3, comparing various treatment combinations.
  • Pancreatic Cancer Studies: PRISM-1 is an ongoing randomized Phase 3 trial aiming to assess new treatment combinations.
  • Kidney Cancer Innovations: PEAK-1 will be pivotal for evaluating the effectiveness of casdatifan alongside cabozantinib for advanced cases.

About Arcus Biosciences

Arcus Biosciences is dedicated to transforming the landscape of cancer treatment through rigorous scientific inquiry and innovative development. Founded in 2015, the company has focused on creating differentiated therapies that address significant unmet medical needs in oncology. With a commitment to exploring novel combination strategies and optimizing treatment protocols, Arcus aims to provide patients with effective solutions that enhance their quality of life.

Frequently Asked Questions

What is the significance of Richard Markus's appointment?

His extensive experience in drug development will bolster Arcus's clinical strategies and help accelerate their cancer programs.

What are the ongoing clinical studies at Arcus?

Arcus is conducting multiple Phase 3 studies, including STAR-221 for upper gastrointestinal cancers and PEAK-1 for renal cell carcinoma.

How does Arcus Biosciences differentiate itself in cancer treatment?

Arcus focuses on developing combination therapies that target multiple pathways, hoping to enhance treatment outcomes for cancer patients.

What areas of cancer treatment is Arcus targeting?

Arcus is targeting various cancers, including gastrointestinal, lung, pancreatic, kidney, and colorectal cancers.

Where can I learn more about Arcus Biosciences?

More information can be found on their official website, which outlines their clinical programs and research initiatives.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Red Banyan Earns Top Honors in Florida for 2026

Updated Category News Views 6

Red Banyan: A Powerhouse in Reputation Management Boy, have you ever watched a company rise through the ranks almost like a caffeine kick on a drowsy morning? That's Red Banyan for you. This outfit, right out of Fort Lauderdale, snagged the '2026 Best of Florida' award as the cream of the crop in the Business Consulting Firms category. It’s like taking home an Oscar in...

Continue Reading
2026 CEE Awards Highlight Energy Innovation Leaders

Updated Category News Views 6

Showcasing Cutting-Edge Home Energy Innovations It's that time of year again when the brightest innovators in home energy solutions get a nod from the Consortium for Energy Efficiency (CEE). This year's Integrated Home Competition spotlighted five trailblazing products that promise to reshape how we think about energy efficiency, demand flexibility, and sheer user comfort...

Continue Reading
ScholarShare 529 Launches $50 Back-to-School Promo

Updated Category News Views 5

California Families Get a Boost With New 529 Plan Offer Everywhere you turn, it's 'back to school' mania right now, and ScholarShare 529 aims to ride that wave by sweetening the pot for parents ready to think ahead. So here's the gist—California's official college savings plan is handing out a $50 gift card for new accounts opened between now and September 30th. Setting...

Continue Reading
Solar Fencing Revolutionizes North Texas Homes

Updated Category News Views 4

Fences Go Solar: Welcome to the Future Land of fences and sunshine, North Texas is about to see a game changer in home improvement. Southwest Fence & Deck is rolling out the red carpet as an Authorized SOL Fence Installation Partner, putting solar power right in your backyard. Yeah, there have been sparks of innovation in plenty of fields, but who expected fences to join...

Continue Reading
Koogler's Sale to ALL4: A Game-Changer for the Southeast

Updated Category News Views 6

A Strategic Alignment Unfolds in Environmental Engineering Ever notice how those industry shifts often sneak up on you, only to leave a mark that's hard to ignore? That's exactly what's playing out with Koogler & Associates' recent hookup with ALL4 LLC. Set aside that coffee, this one's too important to miss if you've got a stake in the environmental consulting game or...

Continue Reading
Ransoms and Mega-Losses Surge in Cyber Claims Study

Updated Category News Views 5

Cyber Costs Skyrocket in Latest Study NetDiligence’s 2026 Cyber Claims Study isn't just another report—it’s a wake-up call. The numbers paint a stark picture: cyber incidents are burning deeper holes in pockets, and no one's immune. Whether you're a scrappy SME or a lumbering corporate giant, this report puts a magnifying glass to the chilling reality of cyber...

Continue Reading
Medicare Competitive Bidding May Slash Jobs, Access

Updated Category News Views 4

Medicare's New Program: Potential Knockout Punch? Today, we dive into Medicare's latest shake-up that might just be the unseen wrecking ball swinging toward thousands of jobs and small businesses in the healthcare sector. Two years from now, starting January 2028, the Competitive Bidding Program is set to reroute the entire landscape for suppliers of key medical products...

Continue Reading
Propensity Rockets to No. 70 on the 2026 Inc. 5000 List

Updated Category News Views 6

Hold onto your hats, folks—Propensity just blasted its way to Number 70 on the Inc. 5000 for 2026. That's quite a leap from the 2,591 spot just last year. If you're scratching your head wondering what's behind this meteoric rise, it’s all about AI and knowing which buyer signals really matter. The AI Advantage in B2B The B2B marketing space isn't exactly the new Wild...

Continue Reading
Lyric Health's AI System Promises Data-Driven Revolution

Updated Category News Views 5

A Bold Step in Healthcare Coordination No doubt about it, healthcare is a mess. It's like trying to patch a leaking ship with duct tape—point solutions here, add-ons there, and nothing truly working in harmony. And in storms in Lyric Health, claiming they've got the answer. They've launched an AI-powered Healthcare Operating System meant to unify these disjointed pieces...

Continue Reading
Goddess Maintenance Co. Eyes BeautyMatter Award

Updated Category News Views 5

Challenging the Haircare Norm with Confidence Goddess Maintenance Co. doesn't just draft a fresh play in the beauty industry playbook—it's ripping out the old pages and setting a new standard. This ain't your granny's haircare game anymore, folks. They're up for a 2026 BeautyMatter Award, a nod to their gut-busting innovation in the conditioner category with their star...

Continue Reading

Top 5 Most Recently Viewed Articles

Vertex Inc Stock Achieves New Heights with Major Milestones

Updated Category News Views 80

Vertex Inc Stock Surges to Unprecedented Values Vertex Inc (NASDAQ: VRTX) has recently experienced a remarkable achievement, as its stock price has soared to an all-time high of $40.09. This significant milestone reflects the company's robust performance in the tax software sector, with its stock value rising a staggering 81.3% over the past year. Investors are...

Continue Reading
Nurturing a Resilient Future in Food Systems Innovation

Updated Category News Views 176

Building Resilient Food Systems Through Innovation Dr. David Lestage, Kellanova's Vice President and Chief Research and Development Officer, emphasizes the critical role of collaboration, science, and technology in fostering resilient food systems. There's an evident shift in our understanding of food and resilience. The prior fragmented discussions surrounding climate,...

Continue Reading
Investors of Ardent, Inc. Urged to Take Immediate Action

Updated Category News Views 118

Ardent, Inc. Shareholders Urged to Take Action Recently, Ardent, Inc. (NYSE: ARDT) has faced significant scrutiny due to alarming developments regarding its financial statements. Purchasing shares during the period from July 18, 2024, to November 12, 2025, may have resulted in severe losses for many investors. Given these circumstances, it’s crucial for affected...

Continue Reading
Exploring the Disconnect Between Viral Trends and Retail Sales

Updated Category News Views 480

Understanding the Gap Between Trends and Retail Reality There's a buzz in the air regarding viral products, commanding attention on various social media platforms. Yet, the reality for retailers may differ significantly from this online hype. Recent research sheds light on this dichotomy, emphasizing the need for retailers to reevaluate their strategies to capture...

Continue Reading
Understanding the Strategic Position of Primary Health Properties

Updated Category News Views 164

Public Opening Position Disclosure and Its Importance The nature of public disclosures in the market plays a crucial role in maintaining transparency for investors, particularly regarding entities that hold significant interests in various securities. This is particularly relevant for organizations such as Primary Health Properties Plc. When a person or entity holds 1% or...

Continue Reading